Treace Files Patent Infringement and Unfair Competition Suit to Protect...
PONTE VEDRA, Fla., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical...
View ArticleLipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative...
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
View ArticleImpact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™...
HOUSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE: IBO), is thrilled to announce a significant milestone in its innovative Linebacker™ technology platform. The Canadian...
View ArticleHealthLynked Files Non-Provisional Patent for AI-Powered Healthcare...
NAPLES, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leader in connecting patients, doctors, and healthcare data, announced the filing of its non-provisional...
View ArticleBioVie Receives Notice of Allowance for Japan Patent Application Covering...
Patents covering BioVie’s terlipressin liquid formulation now secured in the United States, India, Japan and Chile, and are pending in eight additional markets
View ArticleFibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory...
https://www.globenewswire.com/news-release/2024/10/16/2964155/0/en/FibroBiologics-Issued-Patent-for-Fibroblast-Delivery-of-Tumor-Inhibitory-Agents-by-the-European-Patent-Office.htmlHOUSTON, Oct. 16,...
View ArticleClik here to view.
Henry J. Carter Specialty Hospital receives Enhanced Respiratory Care...
New York, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Henry J. Carter is the first long-term acute care hospital (LTACH) and Skilled Nursing Facility (SNF) in New York City to meet the new standard of...
View ArticleAdial Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering...
Expands patent estate covering Adial’s unique molecular genetic approach to diagnosing and potentially treating alcohol and drug dependence Expands patent estate covering Adial’s unique molecular...
View ArticleHPQ Dépose une Demande de Brevet Provisoire pour la Fabrication à Haut Débit...
MONTRÉAL, 22 oct. 2024 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l'ingénierie verte des...
View ArticleHPQ Files Provisional Patent Application for High Throughput Silicon-Based...
MONTREAL, Oct. 22, 2024 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in the green engineering of silica and...
View ArticleGlobal Cancer Antibody Drug Conjugates Market Size Forecast 2030
Global Cancer Antibody Drug Conjugates Market Will Surpass US$ 50 Billion By 2030 Says Kuick Research Global Cancer Antibody Drug Conjugates Market Will Surpass US$ 50 Billion By 2030 Says Kuick Research
View ArticleZenaTech’s AI Drone Company Acquires Drone Design Patent From Former Parent...
TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone solutions and enterprise SaaS...
View ArticleStarton Therapeutics Announces Notice of Allowance for U.S. Patent...
PARAMUS, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary...
View ArticleSolidion Develops a Lithium Battery that can be Charged in 5 minutes With Key...
Solidion is granted a key US patent on a Graphene-Enabled Battery Fast-Charging and Cooling System
View ArticleCan-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia
Namodenoson is an oral drug with a proven favorable safety profile
View ArticleConduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
SAN DIEGO and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announces the filing of two new patent applications relating to...
View ArticleWindtree Announces Expansion of Patents with Issuance of Istaroxime Patent...
Supports Licensing Partner’s Phase 3 Activities in Acute Heart Failure Supports Licensing Partner’s Phase 3 Activities in Acute Heart Failure
View ArticleThe U.S. Patent Trial & Appeal Board Rules in Favor of Extremity Medical on...
Extremity Medical, pioneering novel medical device systems for extremities, survived a challenge by Fusion Orthopedics at US Patent Trial and Appeal Board.
View ArticleEton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral...
- Product has patent protection through 2043 -- Prescription Drug User Fee Act (PDUFA) target action date of February 28, 2025 -
View ArticleDiagnaMed Files U.S. Patent Application for Novel Methods of Producing...
Advancing molecular hydrogen for neurological and mental health disorders
View Article